First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX

Clinical trial NCT00384176 · COMPLETED

Trial details

NCT number: NCT00384176
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2006-08-30
Primary completion: 2009-11-15
Enrollment: 1814

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.